Can LLY Strengthen Its Lead as GLP-1 Price Cuts Reshape the Market?

Eli Lilly LLY and Novo Nordisk NVO, long-standing rivals and the two dominant forces in the GLP-1 obesity market, are now locked in an intensified battle as both companies slash prices to defend and expand their market positions amid soaring demand. Lilly announced meaningful price cuts to its tirzepatide-based obesity drug Zepbound, reducing out-of-pocket costs on […]

States retreat from covering drugs for weight loss

Some states are rethinking their coverage of GLP-1 drugs for weight loss as budgets tighten and Medicaid programs brace for the cuts included in President Donald Trump’s broad tax and spending law.

WHO issues guidance on GLP-1 drugs for obesity, calls them a “scientific breakthrough” and “new chapter” – CBS News

WHO issues guidance on GLP-1 drugs for obesity, calls them a “scientific breakthrough” and “new chapter”  CBS News WHO issues global guideline on the use of GLP-1 medicines in treating obesity  World Health Organization (WHO) World Health Organization issues first-ever guidelines for use of GLP-1 weight loss medications  ABC News WHO warning over shortage of obesity jabs  BBC WHO […]

Nutrients, Vol. 17, Pages 3789: The Effect of a Low-Energy and Low-Glycemic Diet on Adipose Tissue Metabolism and Energy Expenditure in Women with Excess Body Weight

Nutrients, Vol. 17, Pages 3789: The Effect of a Low-Energy and Low-Glycemic Diet on Adipose Tissue Metabolism and Energy Expenditure in Women with Excess Body Weight Nutrients doi: 10.3390/nu17233789 Authors: Ewa Lange Ewelina Pałkowska-Goździk Background/Objectives: Data indicate that a low-glycemic index diet may be an effective nutritional approach to improve cardiometabolic parameters and support weight […]